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First steps to define murine 
amniotic fluid stem cell 
microenvironment
E. Bertin1, M. Piccoli1, C. Franzin1, G. Spiro1,†, S. Donà2, A. Dedja3, F. Schiavi4, E. Taschin4, 
P. Bonaldo2, P. Braghetta2, P.  De Coppi5 & M. Pozzobon1
Stem cell niche refers to the microenvironment where stem cells reside in living organisms. Several 
elements define the niche and regulate stem cell characteristics, such as stromal support cells, gap 
junctions, soluble factors, extracellular matrix proteins, blood vessels and neural inputs. In the last 
years, different studies demonstrated the presence of cKit+ cells in human and murine amniotic 
fluid, which have been defined as amniotic fluid stem (AFS) cells. Firstly, we characterized the murine 
cKit+ cells present both in the amniotic fluid and in the amnion. Secondly, to analyze the AFS cell 
microenvironment, we injected murine YFP+ embryonic stem cells (ESC) into the amniotic fluid of E13.5 
wild type embryos. Four days after transplantation we found that YFP+ sorted cells maintained the 
expression of pluripotency markers and that ESC adherent to the amnion were more similar to original 
ESC in respect to those isolated from the amniotic fluid. Moreover, cytokines evaluation and oxygen 
concentration analysis revealed in this microenvironment the presence of factors that are considered 
key regulators in stem cell niches. This is the first indication that AFS cells reside in a microenvironment 
that possess specific characteristics able to maintain stemness of resident and exogenous stem cells.
Stem cells (SC) are present in all organisms and possess the ability of keeping the undifferentiated state along the 
life span of a living subject or undergoing differentiation on more specialized cell types after specific stimuli. Fetal 
SC are generally defined as broadly multipotent SC because they are more prone to turn into different cell types 
than their adult counterpart. Among those, cKit (CD117) positive cells selected from the amniotic fluid (AF) and 
defined as amniotic fluid stem (AFS) cells may be relevant to therapeutic approaches because they are easy to 
access1,2. AFS cells possess enhanced attitude of growing in culture, along with differentiation ability toward mes-
oderm, ectoderm and endoderm lineages, and can be reprogrammed without viral transfection3. The self-renewal 
capacity and broad multipotency of AFS cells have been proved not only in vitro, but also in vivo; in particular 
it has been demonstrated the ability of AFS cells to replenish the hematopoietic system and the muscle SC niche 
also after secondary transplantation4,5, and to participate in mammary gland regeneration6 highlighting in the AF 
the presence of cells with stemness characteristics. According to the studies that have located and characterized 
the SC niches in mammalian tissues using in situ labeling systems, concrete evidences proved that niches are fun-
damental to maintain SC pool and functions7–9. Along the years it has been proved that distinct classes of niches 
harbor different SC such as the hematopoietic, the neural and the mesenchymal (epidermis, gut and skeletal 
muscle)8–12. Postnatal hematopoiesis occurs mainly in the bone marrow in the best characterized SC niche, where 
hematopoietic stem and progenitor cells reside13. The niche is responsible to define the microenvironment where 
quiescent SC are located before specific signals accomplish the dormant state and activate differentiation process. 
In particular, this dynamic compartment fulfils mainly three functions through secreted or cell surface molecules: 
it controls SC proliferation, determines the fate of SC daughters and protects SC from exhaustion or death.
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It is known that there are common elements constituting the niche: stromal cells that support SC interacting 
with each other via cell surface receptors and soluble factors, extracellular matrix (ECM) proteins that supply 
structural organization and mechanical signals to the niche, vasculature and nervous system that drag systemic 
and physiological inputs14. The role of ECM is of paramount importance because, on one hand, the interac-
tions with ECM provide essential mechanical cues14 and, on the other, the ECM can concentrate growth factors 
and cytokines by binding both local and systemic biomolecules within the niche15. Among all the physiological 
stimuli, oxygen tension has emerged as an important component in different niches, indeed SC that reside in a 
hypoxic niche possess slow-cycling proliferation rates while avoiding the oxidative stress16–19.
The SC in the niche are quiescent and at the same time able to promptly become active because of a global 
balance among all components and signals; consequently, deregulation of this complex equilibrium causes niche 
dysfunction with development of diseases associated with aging20,21, tumorigenesis22,23 and tissue degeneration24. 
Hence, cells within the niche represent possible pharmacological targets with therapeutic potential for some 
diseases.
In the present work, as first study that aim to investigate the characteristics of the extraembryonic microenvi-
ronment, we analyzed the cKit positive cells isolated from the AF and amnion (AM) of mouse embryos. To start, 
we established an in vivo model of in utero transplantation (IUT) with mouse YFP+ embryonic stem cells (ESC) 
used as tool to analyze whether AF and AM were able both to maintain the characteristics of YFP+ ESC and to be 
a specific environment for extraembryonic SC reservoir.
Results
Characterization of extraembryonic mouse cKit+ cells. At first, using the amniocentesis procedure 
(Fig. 1A) we isolated cKit+ cells from AF at different embryonic stages in a time window corresponding approx-
imately to the second trimester of human gestation. In all the analyzed samples, AFS cells were present in a var-
iable proportion according to the gestational age (Fig. 1B,C). Specifically at E11.5 in AF there was a peak in the 
percentage of AFS cells that slowly decreased in the next days (Fig. 1B) without significant differences. However, 
the total number of AFS cells per embryo equivalent (10.000–20.000 cells per embryo, Fig. 1C) was similar in all 
the analyzed time points, suggesting the idea that AFS cells are present in equal number in each AF until birth. 
After isolation, we investigated the frequency of SC marker expression at single cell level by multiplex PCR, from 
E11.5 to E14.5 (Fig. 1D), showing that cMyc, Klf4, Sca1 and Sox2 were expressed in all the analyzed embryonic 
stages, even if at different frequency. Interestingly Oct4 was present in 2%, 11% and 76% of cells respectively at 
E11.5, E12.5 and E13.5, while there were no positive cells at E14.5. Cells isolated at E13.5 displayed the expression 
of pluripotency genes Oct4, Sox2, cMyc and Klf4 on a considerable frequency (76%, 10%, 45% and 55%, respec-
tively) and the majority of the cells co-expressed more than one gene (Table 1). For these reasons, we focused 
all the further experiments at this gestational age. We discovered only few proliferating EdU+ cells (4.5 ± 10%, 
Fig. 1E) and according to the immunophenotype, the majority of cKit+ cells co-expressed mesenchymal mark-
ers such as CD44, CD90, CD105 and Sca1 (Fig. 1F, supplementary Fig. 1). Since the contiguity between AF 
and AM, we decided to investigate whether it was possible to isolate cKit+ cells also from this membrane4. This 
population represented 5.8 ± 4.9% of total cells at E13.5 (Fig. 1G,H) and about 17 ± 36% of AM cKit+ cells were 
EdU+ (Fig. 1I). We then analyzed the frequency of SC marker expression at single cell level and detected a lower 
percentage of cells positive for cMyc (18%) and Klf4 (42%) (Fig. 1L) in respect to cells in the AF at the same ges-
tational age (Fig. 1D), but most importantly no Oct4 positive cells were found in cKit+ AM population (Fig. 1L), 
indicating a more committed phenotype of cKit+ cells isolated from the membrane in respect to those floating 
in the fluid.
Characterization of extraembryonic mouse environment. In order to better characterize the SC pop-
ulation residing in AF, we sought to deeper analyze the environment in which these cells live for a physiologically 
time-restricted period. Mouse AM is an avascular membrane composed of two cell monolayers that express 
developmental markers, such as α SMA, Afp, Tubb3, the adhesion molecule E-Cadherin (Fig. 2A,B), and typical 
markers of stromal cells like CD29, CD44, CD90 and Sca1 (Fig. 2D, supplementary Fig. 1). We did not detect 
expression of specific endothelial markers such as CD31, neither the presence of the angiogenic cytokine VEGF 
(Fig. 2C). Differently, the AM seems to be rich in other molecules, which have typically an effect on cell growth 
and migration such as SCF, HGF and IGF (Fig. 2C). Interestingly, the same cytokines were monitored also in the 
AF during the course of the murine gestation, from E11.5 to E17.5, and were all present with a specific trend, 
suggesting a very complex and orchestrated signal environment (Fig. 2E). Since oxygen tension plays a crucial 
role in SC homeostasis especially in the niche, we investigated this aspect regarding AM and AF cells. To this 
aim, the hypoxic marker piminidazole (Pimo) was injected in tail vein of pregnant females, which were sacrificed 
2 hours post injection. When Pimo is administered in vivo, it forms stable adducts in hypoxic regions that can 
be subsequently identified with an anti-Pimo antibody. We evaluated the presence of Pimo positive cells by flow 
cytometry and immunofluorescence, both in AF and AM, and bone marrow was used as positive control (data 
not shown). Flow cytometry revealed 11.3% and 1.8% of Pimo+ ckit+ cells respectively in the AF and in the AM 
(Fig. 2F). Regarding the cKit positive population we found 88.9% of Pimo+ cells in the AF and 91.9% in the AM. 
When we evaluated the hypoxic profile by immunofluorescence, we detected 95.9 ± 2.1% of Pimo+ cells in the 
AM (Fig. 2G), similar to the value observed by flow cytometry, and 59.3 ± 5.3% of Pimo+ cells in the AF (Fig. 2G), 
slightly different to the analysis using flow cytometry but still pointing out that the majority of the AFS cells are 
in a hypoxic condition.
IUT injection of ESC. We performed IUT experiments (listed in Table S1) injecting 105 YFP+ ESC into the 
amniotic cavity of E13.5 wild type embryos and then analyzed the YFP+ cells isolated from AF, AM and embryos 
4 days after injection (i.e. E17.5, Fig. 3A). To design the injection strategy we performed IUT experiments with 
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different number of ESC injection: 104, 105 and 106 (experiments n = 6) per embryo, and, while 104 cells were not 
sufficient to perform analyses after transplantation, in utero injection of 106 cells caused death of embryos (21% 
overall survival compared to 82% survival with injection of 105 ESC, Table S1). Then we set 105 cells as standard 
cell number to be injected in the AF at E13.5. To be able to retrieve AF and to avoid delivery that happen at E19.5, 
4 days after IUT AF and AM were collected: we detected YFP+ cells ranging from 0.3 to 28.8% in the AF and 
from 1.2 to 13.5% in the AM (Fig. 3B). YFP+ ESC were also analyzed under the proliferative and apoptosis aspect: 
we identified around 6.3 ± 6.2% and 8.1 ± 2.2% EdU+ cells in the AF and AM respectively (Fig. 3C). These data 
suggest that ESC reside in the AF and AM mainly in a non-proliferative or quiescent state, with a small number of 
cells in active proliferation. Despite Tunel assay did not evidenced apoptotic or dead YFP+ cells (data not shown), 
we were able to recover about 104 ESC from each embryo (1000–2000 ESC from AF and 8000–9000 ESC from 
AM), 10 times less than the injected cells. Nevertheless, this cell number was sufficient to perform all the analyses. 
These numbers are referred to YFP positive cells, although randomly ESC loose, for some unknown mechanism, 
the YFP expression when in vitro expanded (data not shown) and as consequence it can not be excluded to 
Figure 1. Characterization of cKit+ cells isolated from the murine AF and AM. (A) Amniocentesis 
procedure, from the removal of the fetal membrane to the collection of the AF. (B) The percentage of AFS 
(cKit+) cells at different embryonic stages. Mean is represented by bar. (C) Total number of AFS cells per 
embryo equivalent (EE). Mean is represented by bar. (D) Frequency of AFS cells positive for the expression of 
each gene (cKit, cMyc, Klf4, Nanog, Oct4, Sca1, Sox2) at different embryonic stages evaluated by single cell PCR 
(E11.5: 49 cells (n = 7 embryos); E12.5: 38 cells (n = 9 embryos); E13.5: 42 cells (n = 31 embryos); E14.5: 52 cells 
(n = 10 embryos)). (E) Representative immunostaining showing some EdU+ cells among the cKit+ cells isolated 
from AF (n = 7 embryos). (F) Flow cytometry analysis highlighted the presence of AFS cells positive for the 
markers CD44, CD90, CD105 and Sca1 (n = 31 embryos). (G) Representative immunostaining showing cKit+ 
cells in the AM (n = 3 embryos). (H) Percentage of cKit+ cells isolated from AM. (I) EdU+ cells among the cKit+ 
cells isolated from AM (n = 7 embryos). Scale bars = 100 μ m. (L) Frequency of E13.5 ckit+ AM cells positive 
for the expression of each gene (cKit, cMyc, Klf4, Nanog, Oct4, Sca1, Sox2) studied by single cell PCR (50 cells 
(n = 18 embryos)).
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underestimate the number of ESC rescued after IUT. We decided to use ESC not for therapeutic purposes but only 
as experimental tool being the best-defined SC source, nevertheless, since fetus is part of the microenvironment, 
we asked whether injected YFP+ ESC were located only within the AF and AM or integrated in the embryo tis-
sues eliciting modifications in the mouse development. At first, histological analysis highlighted that the embryo 
structure was not impaired by cell injection since no organ abnormalities were detected (supplementary Fig. 2A) 
even in tissues analyzed six weeks after birth (supplementary Fig. 2C). Secondly, we evaluated YFP presence by 
PCR and by immunofluorescence analysis and in 3 out of 13 analyzed embryos YFP expression was detected 
(supplementary Fig. 2A,B), whereas rare ESC were found only within the airway spaces (supplementary Fig. 2A).
ESC maintain pluripotent characteristics after IUT. Since ESC may spontaneously differentiate in 
absence of proper stimuli (supplementary Fig. 3), it was of paramount importance to establish if ESC main-
tained pluripotent state after IUT. Therefore in YFP+ ESC isolated from AF (ESC AF) and AM (ESC AM) PCR 
and immunofluorescence analyses were performed. As shown in Fig. 4A, the gene expression levels of cMyc, 
Klf4, Nanog, Oct4 and Sox2 detected in ESC AF decreased significantly compared to ESC before injection. On 
the contrary, the expression profile of ESC AM was similar to that of the ESC before IUT (Fig. 4A), suggesting 
a possible role of the AM for pluripotency maintenance. We also analyzed at single cell level the expression of 
each stemness gene in ESC AF and AM 4 days after injection. While cells isolated from AM proved to be similar 
to the control ESC in terms of frequency of SC markers expression, ESC AF reduced the expression frequency 
of all the studied genes (Fig. 4C). Furthermore, the percentage of cells co-expressing two or more pluripotent 
genes was similar between ESC before IUT and those isolated from AM, whereas only in few ESC AF Oct4 and 
Nanog were simultaneously expressed (Fig. 4D). Interestingly, after isolation, both ESC AF and AM retained the 
expression at protein level of the pluripotency markers Oct4, Sox2 and Nanog (Fig. 4B). To investigate whether 
ESC AM and AF diverged also in the ability to differentiate into cells of the three germ layers as well as in terms of 
gene expression both at population and single cell level, we injected IUT YFP+ ESC in the hindlimbs of immuno-
compromised mice. In more detail, ESC post-IUT were collected keeping distinguished those isolated from AF 
and AM, and injected into the inner part of leg of Rag2−/−γ c−/− mice. We already tested the inability of AF and 
AM cells to form teratoma (data not shown) and for this reason, ESC after IUT were not FACS sorted since any 
tumor mass that would appear would have been the consequence of the injected pluripotent ESC. Moreover ESC 
after IUT were not in vitro expanded before the teratoma assay, but directly injected in the muscle immediately 
after collection. The injected ESC, obtained after IUT, were not less than 105 since we isolated them from 100 
transplanted embryos. To be sure about the minimum ESC (pre-IUT) number sufficient to generate a teratoma, 
we injected mice with 104, 105 and 106 ESC pre-IUT and identified the presence of tumor masses 6 weeks after 
injection only in the condition with 105 and 106 cells (supplementary Fig. 3B). We identified that ESC AF were 
not able to generate tumor, instead ESC AM gave rise to defined masses as highlighted in Fig. 4E by the gross 
appearance and the YFP immunostaining (Fig. 4E). The tumors were composed of cells displaying expression 
of genes characteristic of all three germ layers, as evidenced by histological and PCR analyses (Fig. 4F). Taken 
together, these results clearly indicate that only ESC attached to the AM after the 4 days in the amniotic cavity 
were able to maintain their pluripotency in terms of SC gene expression and ability to form differentiated cells 
from mesoderm, ectoderm and endoderm embryonic layers. Due to these results we hypothesized that AM acts 
as stromal support for the stemness maintenance of ESC, as showed also in other studies which used AM as 
in vitro stromal support25,26. We performed the staining of ESC expanded in vitro for 4 days (same time interval as 
for IUT transplantation) onto the whole AM, obtained from embryos at E13.5, in a basal medium (without LIF). 
ESC in this condition formed the characteristic colonies, which were positive for the expression of Oct4, Sox2 
and Nanog (supplementary Fig. 4). These findings validate our hypothesis that considers AM as stromal support.
IUT injection of AFS cells. On the basis of the results obtained with the gene expression analysis of the 
cKit+ cells from AF and AM (Fig. 1), which showed that AFS cells had a higher frequency of pluripotency marker 
expression in respect to homologous cells isolated from the AM, we decided to perform AFS IUT. We trans-
planted 104 AFS cells per embryo (n = 7 embryos), following the same procedure used for ESC. We evaluated, by 
flow cytometry analysis, the percentage of cKit+ cells identified at E17.5 in the AF and AM, comparing between 
non-injected (defined WT) and injected (IUT AFS) (Fig. 5). We pointed out an increase of cKit+ cells in the AF 
10.5 11.5 12.5 13.5 14.5
ko 0% 0% 10% 43% 0%
ks 0% 2% 13% 5% 0%
km 11% 18% 8% 12% 2%
kom 0% 0% 0% 9% 0%
koms 0% 0% 0% 0% 0%
sm 7% 2% 0% 2% 2%
so 0% 0% 0% 7% 0%
om 0% 0% 0% 33% 0%
kos 0% 0% 0% 5% 0%
Table 1.  Frequency of co-expression of pluripotency genes in mouse AFS cells. k = Klf4; m = cMyc; o = Oct4; 
s = Sox2.
www.nature.com/scientificreports/
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after IUT, suggesting that AFS seem to prefer the AF localization in respect to the AM, on which only a low per-
centage of cells adhered during the experimental period.
Discussion
CD117/cKit is a marker that identifies the SC population in the AF, namely the AFS cells; we investigated the 
microenvironment where these cells are floating to seek whether the fundamental elements forming a SC niche 
could be uncovered. At first, we performed gene expression analysis in cKit positive cells isolated from AF, show-
ing that the embryonic stage 13.5 was the best time point in terms of pluripotency markers expression. Single 
cell PCR analysis, previously used to identify variable gene expression of ESC colonies27, revealed the genetic 
heterogeneity of AFS cell population.
Then we compared cells from AF and AM, at E13.5, seeing that AFS cells had a higher frequency of pluripotency 
markers expression in respect to homologous cells isolated from the AM. This finding indicated a higher stemness 
level of cKit+ cells in AF in comparison to the population identified in the surrounding membrane. We previously 
demonstrated the ability of mouse AFS cells to differentiate into different tissues (muscle and hematopoietic)4,5  
but they are not pluripotent cells. In fact, when injected into an immunocompromised mouse they do not form 
teratoma. An analogous result was obtained with cells isolated from AM. Since Nanog together with Yamanaka 
factors, plays a pivotal role in the establishment of the pluripotent state and, in concert with Oct4, also in its 
maintenance28–30, the absence of its expression leads us to define these cKit positive cells as broadly multipotent 
rather than pluripotent.
Given that AFS cells own SC behavior and express stemness markers, we wondered if these characteristics are 
maintained in vivo by the extraembryonic microenvironment. Therefore we studied the AM, observing that this 
Figure 2. The extraembryonic stem cells niche: AM, cytokines and hypoxia. (A) Histological analysis of the 
AM and (B) representative images of immunostaining for α SMA, Afp, Tubb3 and E-Cadherin (n = 5 embryos). 
(C) Cytokines detection and analysis on AM obtained at the embryonic day 13.5. Analyzed cytokines: mouse 
SCF; mouse VEGF; mouse HGF; mouse IGF (n = 25 embryos). (D) AM flow cytometry analysis highlighted the 
presence of cells positive for the mesenchymal markers CD29, CD44, CD90 and Sca1 and negative for CD31 
and CD105 (n = 20 embryos). (E) Cytokines detection and analysis on AF obtained at different embryonic days 
(E11.5, E12.5, E13.5, E16.5 and E17.5). Analyzed cytokines: mouse SCF; mouse VEGF; mouse HGF; mouse IGF 
(n = 60 embryos). (F) Flow cytometry analysis confirmed the presence of Pimo+ cells in the AF and AM (n = 6 
embryos). (G) Immunostaining of Pimo demonstrated the presence of different percentage of hypoxic cells 
between AF and AM. (***p < 0.01) (n = 8 embryos). Scale bars = 100 μ m.
www.nature.com/scientificreports/
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membrane conveys different stromal markers, including E-Cadherin, a fundamental protein for SC anchorage to 
the niche31. Secondly, we evaluated the presence and the concentration of cytokines and growth factors that were 
demonstrated to play a central role also in other SC niches. We detected SCF, which is a master regulator of the 
self-renewal and differentiation in the hematopoietic niche32, HGF and IGF-1, both key factors for the expansion, 
self-renewal and differentiation of the defined niche of satellite cells33, and VEGF which is involved in cell pro-
liferation during embryogenesis34. Oxygen tension evaluation by means of the marker Pimo, which detects cells 
that experience an oxygen concentration around 1.3% (10 mmHg), revealed that cKit+ cells both in the AM and 
AF live in low oxygen tension (hypoxia) environment. Together with structural and soluble factors, hypoxia is 
essential for the stemness maintenance of embryonic, hematopoietic, mesenchymal and neural SC, and could also 
influence proliferation and cell-fate commitment35.
We are aware that this is the first study facing the aspect of defining the extraembryonic SC niche, indeed more 
than fifty years of research investigations have been dedicated to the most studied SC niche such as the hemato-
poietic one9. So far, all the analyzed aspects suggested that the extraembryonic environment displays features that 
could parallel it to a specific niche. However, to really prove this, it is necessary to deplete the extraembryonic 
environment of its own SC and demonstrate the ability to accept and maintain a newly introduced SC popula-
tion36. Indeed, this is what happens when hematopoietic SC from a donor replenish the irradiated bone marrow 
of a host organism or when an empty Drosophila SC niche attracts foreign somatic SC and transiently maintain 
their characteristics37. In this view, although in the future we plan to study the way of AFS cells depletion, we 
decided to use an exogenous SC population such as mouse ESC38,39 as a tool to investigate the possible existence 
of an extraembryonic SC niche by their injection into the amniotic cavity. Importantly, mouse ESC proved to 
be a good tool since these cells can maintain the pluripotency also when are floating. A protocol published by 
Andang et al.40 showed that with the presence of correct stimuli these cells keep their characteristics also when 
are in suspension. In addition, it has already been demonstrated that fetal microenvironment may participate in 
the control of ESC growth41, indicating that there are strong differences between adult and fetal environment. 
Usually, when ESC are transferred into a foreign environment, an uncontrolled differentiation program is acti-
vated leading to the formation of a disorganized multicellular mass, which contains a multiplicity of cell types, 
namely teratoma42. The absence of an appropriate microenvironment created by specific intercellular interactions, 
systemic inputs and cellular organization, causes the disorganized ESC differentiation. Conversely, when ESC are 
injected into their native niche, or rather a recipient blastocyst, they contribute to the generation of all tissues of 
the new organism43. In the last decades, in vitro experiments were performed to establish which conditions and 
inputs are necessary to maintain pluripotency when ESC are cultured in a dish, allowing their expansion and 
controlled differentiation for a wide range of purposes. An ESC culture bases on a dynamic equilibrium between 
cells that self-renew and others that differentiate mainly under the control of a small transcription factor network 
with three core components: Nanog, Oct4 and Sox228. This fragile equilibrium is highlighted by the stemness gene 
expression at single cell level: not all the cells co-expressed the pluripotency genes27,44–46, but this is in step with 
the fact that quiescence, proliferation and differentiation processes are dynamic events inside a SC population. 
It is important to underline that we used ESC to investigate the capacity of the extraembryonic environment to 
maintain the characteristics of foreign cells and not for therapeutic purposes; considering this aim, E13.5 was the 
suitable gestational age to perform IUT because the embryo at this stage has the dimension to allow the injection 
into the amniotic cavity without damaging the fetal structures. Moreover the majority of the fetal organs are 
completing their development, giving us an higher probability that cells would stay in the AM and AF without 
been attracted by the embryo. When we injected YFP+ ESC into the amniotic cavity, we observed that they did 
Figure 3. Experimental plan and in vivo cell detection. (A) YFP+ ESC were injected into the amniotic cavity 
of embryos at E13.5 and 4 days after injection AF, AM and embryos were analyzed (n experiments = 24). 
(B) FACS analysis of cells isolated from AF and AM after IUT (n = 16 embryos). (C) Immunostaining and 
quantification of EdU+ cells among all the YFP+ ESC isolated from AF and AM after IUT (n = 8 embryos).
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not integrate into the embryos, probably because at the embryonic stage of 13.5 there are not the mandatory 
stimuli for ESC to take part to the organogenesis, and we did not detect tumor masses in mice born after IUT. In 
addition, only a small number of ESC were EdU+, to indicate the absence of proliferation inputs, as it occurs in 
other niches47, and we did not found apoptotic cells. For these reasons, we believe that ESC were accepted from 
the extraembryonic environment, as confirmed also by the high survival rate (82%) of the embryos after IUT. On 
the contrary, when we injected ESC in the fetal abdominal cavity, a liquid microenvironment structurally similar 
to the AF but characterized by different stimuli, we did not retrieve any YFP+ cells (data not shown). This is in 
keeping with several published works demonstrating that cells intraperitoneally and intravenously injected at 
Figure 4. Characterization of YFP+ ESC after IUT and in vivo teratoma formation. (A) PCR analysis of 
pluripotency markers (cMyc, Klf4, Nanog, Oct4, Sox2) on YFP+ ESC populations before IUT (black bars) and 
after IUT obtained from AF (dark grey) and AM (light grey) (n = 34 embryos). (*p < 0.05) (B) Characterization 
of stem cell protein expression in ESC after retrieval and FACS sorting from AF and AM (n = 26 embryos).  
(C) Frequency of cells positive for the expression of each gene in the YFP+ ESC after IUT obtained from AF 
(dark grey; 32 and 50 cells (n = 25 embryos) and AM (light grey; 18 and 44 cells (n = 31 embryos), considering 
YFP+ ESC before IUT (53 and 51 cells) as 1. (D) Percentage of cells co-expressing each gene (N = Nanog; 
O = Oct4; S = Sox2) in the analyzed populations. (E) Macroscopic aspect of Rag2−/−γ c−/− mice hindlimbs 
sacrificed 6 weeks after injection of YFP+ ESC post IUT (n = 100 emrbyos). Tumor masses were visible only 
in mice transplanted with YFP+ ESC obtained from AM; immunostaining of YFP and Laminin confirmed the 
absence of ESC cells in muscle transplanted with YFP+ cells isolated from AF, while tumor masses obtained 
from ESC AM resulted positive for YFP expression. (F) Histology and immunostaining of teratomas confirmed 
the cell differentiation into all three germ layers (ectoderm, mesoderm and endoderm). PCR analysis of two 
teratoma samples (T1 and T2) obtained after injection of ESC AM. Tumor masses resulted positive for the 
expression of β3 tubulin (Tubb3, ectoderm), vimentin (Vim, mesoderm) and αfetoprotein (Afp, endoderm). 
C+ = positive control, NTC = not template control. Scale bars = 100 μ m.
www.nature.com/scientificreports/
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E13.5 are rejected in immunocompetent fetuses48–51. Following these results, we can underline that, in immu-
nocompetent mice (such as our model), there is a strong difference between IUT of ESC injected in the AF or 
intraperitoneally in the fetus. In the first condition, ESC are rescue while in the fetus cells are rejected due to lack 
of immunotolerance. Moreover, the fact the ESC are not rejected in the AF indicates that this is also a privileged 
environment.
When we analyzed ESC isolated after IUT we found that ESC floating in the AF strongly reduced the gene 
expression of the pluripotency markers and lost the ability to form teratoma, while this did not occur to ESC 
attached to the AM. These findings suggest a role of the AM as stromal support able to maintain ESC charac-
teristics, as demonstrated when we cultivated ESC onto the whole AM in vitro. Amniotic membrane is rich in 
stromal cells and secretes cytokines and growth factors, such as SCF, HGF and IGF, that are produced by cell lines 
(i.e. STO and CF-1) usually employed as feeder layer in vitro for ESC expansion52. Moreover, Bashamboo et al.53 
showed that in vitro ESC differentiation is dependent on the SCF-KIT pathway, and Chen et al.54 demonstrated 
how a signalling by vitamin A/retinol promotes the self-renew of ESC through the activation of PI3K/Akt signal-
ling via IGF-1 receptor. According to what has been shown for the Drosophila germ stem cell (GSC) niche, the 
direct interaction between SC and somatic neighbors is fundamental for the stemness maintenance. In the GSC 
niche, the responsible of the intercellular connection and cross-talk are cadherins and catenins, which constitute 
the adherent junctions that are the physiological link between cells and stroma. Molecular studies proved that 
mutations in these junctions lead to the inability of the somatic cells in recruiting and maintaining the GSC55. 
Moreover, E-cadherin seems to play an essential role in balancing ESC self-renew and differentiation56, and for 
this reason the E-Cadherin expression by AM cells could further sustain the hypothesis of a role as stroma sup-
port. Following this idea, different studies already showed the ability of AM membrane to sustain stemness char-
acteristics in vitro25,26. A more extensive investigation to identify which signaling pathways could be responsible 
of the maintenance for pluripotency of ESC in the AM will be necessary to better understand the extraembry-
onic microenvironment. In the prospective stemness of AFS cells, it could be hypothesized that the AM is more 
important for the cytokines and soluble factors produced rather than for its stromal support, since the AFS cells 
are naturally floating in the AF. Indeed when we injected AFS cells, more cells were found on AF rather than AM. 
The process of floating in AF and attaching to AM of both injected ESC and endogenous AFS cells is probably 
dynamic. Nevertheless, the two cell types are different: AFS cells are not pluripotent and physiologically floating, 
ESC are pluripotent and naturally grow in cell agglomerates (blastocyst) or colonies. Indeed, after IUT we found 
each cell type according to their stemness: broadly multipotent AFS cells in AF and pluripotent ESC on the AM 
stromal support.
In conclusion, having already demonstrated the ability of AFS cells to both replenish and stimulate a damaged 
niche5,57, here we showed the ability of the extraembryonic environment, delimited by the embryo and its mem-
branes, to sustain exogenous SC features. It has been proved58 that the characteristics elicited by this environment, 
Figure 5. Detection of AFS cells after IUT. Flow cytometry analysis and quantification of cKit+ cells isolated 
from AF and AM at E17.5 in the non-injected (WT) and injected (IUT AFS) condition. (***p < 0.01) (n = 7 
embryos).
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such as soluble factors and low oxygen levels (hypoxia), are essential regulators for the maintenance of AFS cell 
stemness. Further experiments are necessary to establish the physiological role of AFS cells and they interaction 
with the microenvironment, but starting with these evidences we believed that AM and AF could be considered 
the murine extraembryonic SC niche.
Methods
Mice. All surgical procedures and animal husbandry were carried out in accordance with international guide-
lines, with the National Institutes of Health Principles of Laboratory Animal Care (National Institutes of Health 
publication 85–23, revised 1985) and were also approved by the local ethics committee for animal care of the 
University of Padova (organismo per il benessere degli animali, or OPBA). C57BL/6 J pregnant mice were used 
for cell isolation and transplantation and Rag2−/−γ c−/− mice for teratoma assay.
Amniotic fluid, amnion collection, cell selection and flow cytometry. Embryo age was defined rel-
ative to the morning of vaginal plug discovery (E0.5). All dissections were performed under a stereomicroscope 
(Leica Microsystems) and AF was collected following the procedure described elsewhere4.
During the amniocentesis also AM membranes were collected, AM were stretched on a glass slide and fixed for 
immunostaining or digested with 0.2% collagenase I (Sigma-Aldrich) supplemented with 3% fetal bovine serum 
(FBS, Life Technologies) to isolate cells. cKit/CD117 positive cells (from AF and AM) were isolated using the 
Miltenyi Mouse Lineage Cell depletion kit and then CD117 Microbeads (all from Miltenyi Biotech). Cells were 
counted using a Burker chamber, characterized by the presence of cell markers such as CD44, CD90, CD29, Sca1, 
CD31, and CD105 (all from BD-Biosciences) and analyzed with Accuri C6 Flow Cytometer (Becton Dickinson). 
Rat IgG 2a FITC-, rat IgG2a PE- and rat IgG2b APC-Isotype were used as negative control. Total number of AFS 
cells per embryo equivalent (EE) was defined as the number of cKit+ cells divided for the number of embryos.
Mouse YFP embryonic stem cells culture. Mouse YFP+ embryonic stem cells (YFP+ ESC), produced by 
Janet Rossant and Dr. John Roder’s laboratory, were kindly provided by Dr. Andras Nagy and Kat Hadjantonakis 
of Mount Sinai Hospital in Toronto. YFP+ ESC were maintained for different passages under standard culture 
conditions, on inactivated mouse embryonic fibroblasts (MEF) and in the presence of LIF59. Cells were detached 
and prepared for transplantation. YFP+ ESC were also maintained onto whole AM for 4 days, in a basal medium 
without LIF.
Assessment of the hypoxic profile. The hypoxic status of AM and AF cells was assessed using 
Hypoxyprobe-1 Plus Kit (HPI). Pregnant mice (E13.5) were intravenously injected with 120 mg kg−1 of piminida-
zole (Pimo) 2 hours before euthanasia. Cells obtained from AF and AM were used for FACS analysis or stained. 
For the FACS analysis, cells were permeabilized using IntraPrep Kit (Beckman Coulter) following the manufac-
turer’s procedure, while for immunofluorescence onto cytospin AF or AM cells were fixed using 4% PFA and 
permeabilized with 0.1% triton X-100. Detection of intracellular Pimo adducts was performed labeling with 
FITC-conjugated mouse anti-Pimo antibody. PBS-injected mice were used as controls to detect baseline levels of 
anti-Pimo antibody binding.
In utero transplantation and sample preparation. Dams at E13.5 were anesthetized using 3% iso-
fluorane in oxygen. A midline laparotomy was performed to expose uterus and 10 μ L of PBS containing 1 × 105 
YFP+ ESC or 1 × 104 AFS cells were injected within AF of each embryo using hamilton syringe fitted with a 33 G 
needle. After transplantation analgesic was administered into abdominal cavity before suturing.
After 4 days, at E17.5, every single embryo was isolated and AM and AF were collected. AM membranes were 
digested with collagenase I as previously described in “Amniotic fluid, amnion collection and cell selection”; AF 
was centrifuged to separate the cells. AM and AF cells were sorted with FACSAria (Becton Dickinson) for the 
expression of YFP or cKit (7-Amino-actinomycin D - 7AAD (BD-Biosciences) was added as a viability marker 
in the sorting procedure) and isolated ESC were analyzed. Embryos were paraffin embedded or snap-frozen for 
histology, immunostaining and PCR analyses. In one experiment mice were sacrificed after IUT, at six weeks after 
birth, organs were collected and snap-frozen for histology or immunofluorescence analysis.
Analysis of EdU incorporation. Pregnant female mice (E13.5 and E17.5 post-IUT) were injected intraperi-
toneally with 0.5 mg of EdU (Click-iT Edu Imaging Kit, Life Technologies). Cells were collected from AF and AM 
3 hours after the injection, in the case of IUT ESC were sorted for YFP, fixed using 4% PFA and then cytospinned. 
Immunofluorescence has been performed following manufacturer’s instructions.
Cytokines analysis. Stem cell factor (SCF MCK00, R&D Systems), vascular-endothelial growth factor 
(VEGF MMV00, R&D Systems), hepatocyte growth factor (HGF MHG00, R&D Systems) and insulin growth 
factor (IGF-1 MG100, R&D Systems) were analyzed in the AF at different gestational ages and AM at E13.5, using 
specific ELISA quantikine kit.
DNA/RNA extraction. DNA from embryos was extracted with a DNeasy Blood & Tissue kit (QIAGEN). 
RNA from YFP+ ESC before and after IUT, teratoma and positive controls (muscle, fetal liver, embryos, brain) 
was extracted using RNeasy Mini Kit (QIAGEN) following the manufacturer’s instructions.
RNA and DNA were quantified with a Nanodrop ND-2000 spectrophotometer (Thermo Scientific).
PCR and Realtime PCR. GFP+ and WT embryos were used, respectively, as positive and negative con-
trols for the detection of the YFP expression. For the germ layer markers the following positive controls were 
used: fetal liver from at E13.5 embryo for the Afp, embryo at E9.5 for Vimentin and adult brain for Tubb3. PCR 
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reactions were carried out as previously described5. Real-time PCR reactions for the pluripotency genes were 
carried out in triplicate with Lc Faststart Dna Masterplus Sybr (Roche) in a LightCycler II instrument (Roche), 
using 5 ng of cDNA and a 300 nM solution (final concentration) of specific forward and reverse primers. For 
the quantification, standard curves were prepared using 50 ng of cDNA from a pool of ESC serially diluted 1:5 
for five standard points. Results are presented as the ratio of target gene mRNA content to housekeeping gene 
mRNA content expressed in arbitrary units. B2m was used as housekeeping gene. For primers specification see 
supplementary Table 2.
Single cells deposition. Cells isolated from AF, at different embryonic stages, and AM were sorted for cKit 
expression as well as YFP+ ESC before and after IUT (isolated from AF and AM) were sorted for YFP expression 
using a FACS Aria I Sorter equipped with an automatic cell deposition unit (Becton Dickinson). 7AAD was added 
as a viability marker in the sorting procedure. Each cell was collected in single well of 96-well plates for molecular 
biology containing 5 μ L of PBS-DEPC 0.1%, and stored at − 80 °C.
Single-cell multiplex PCR. We followed the protocol described in Franzin et al.27. Results are expressed as 
frequency of expression, that is the percentage of cells positive for each gene (cKit, cMyc, Klf4, Nanog, Oct4, Sca1, 
Sox2) on total analyzed cell number.
Histology. Embryos obtained after IUT were washed in distilled water, dehydrated in ethanol gradient, left 
overnight in paraffin and sections were made using microtome.
Hematoxylin and eosin stain was performed with Hematoxylin/Eosin (HE) kit for rapid frozen section 
(Bio-Optica). Sections were observed by Olympus BX60 microscope (Olympus). Pictures were taken using 
Viewfinder Lite software.
Immunofluorescence. Transverse sections of embryos or organs (7–10 μ m thick) and AM tissue were fixed 
with 4% PFA and permeabilized with 0.5% triton-X 100 in PBS. The presence of YFP+ ESC was revealed using 
anti–GFP 594 antibody (1:150).
YFP+ ESC before and after IUT were fixed with 4% PFA and permeabilized using 0.1% NP-40. For stain-
ing have been used (1) the primary antibodies Oct4 (1:80), Sox2 (1:80) and Nanog (1:100) for cells; (2) cKit 
(1:80), α smooth muscle actin (α SMA; 1:100), α fetoprotein (AFP; 1:200), β III tubulin (Tubb3; 1:500), E-cadherin 
(1:100) for AM membrane; (3) anti–GFP 594 antibody (1:150) for organs and embryos, (4) Hoechst (1:1000, Life 
Technologies) for nuclei detention. Cells and tissue slides were observed under inverted immunofluorescence 
microscope (Leica DMI6000B, Leica Microsystems Srl). For antibodies specification see supplementary Table 3.
Teratoma. For teratoma assay about 1 × 105 or 1 × 106 mouse YFP+ ESC (pre- and post-IUT; cells after IUT 
were collected from 100 embryos keeping distinguishing between those isolated from AF and AM) were injected 
into the muscle of the hindlimb of Rag2−/−γ c−/− mice straight after isolation from AF and AM digestion. After 
6 weeks, mice were sacrificed and tumors collected for following analyses. Transverse sections (7–10 μ m thick) 
of isopentan-frozen muscles were stained with hematoxylin and eosin to evaluate the tumor tissue composition.
For immunoperoxidase staining, teratoma sections were fixed using 4% paraformaldehyde (PFA) and perme-
abilized with 0.1% triton X-100. β III tubulin (1:100), α fetoprotein (1:50) and α SMA (1:100) primary antibod-
ies were diluted in 1% BSA in PBS and incubated for 1 hour at 37 °C (for β III tubulin) or overnight at 4 °C (for 
others). After peroxidase blocking, secondary antibody HRP-conjugated was incubated for 45 minutes at 37 °C. 
After incubation with ImmPACT NovaRED (Vector Laboratories) for 5 minutes, cytoplasm was stained with 
Hematoxylin (Vector Laboratories) for 9 seconds.
For immunofluorescence analysis anti–GFP 594 antibody (1:150) and anti-Laminin antibody (1:100) were 
used. For antibodies specification see supplementary Table 3.
Statistical analyses. Data were expressed as means ± s.e.m. Statistical significance was determined by using 
an equal-variance Student’s t-test and a p-value below 0.05 was considered to be statistically significant.
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